Concomitant immunity to Schistosoma mansoni in mice

Abdel-Moneim Salim1, Abdel-Rahman Al-Humiany

  • 1Department of Medical Microbilogy, Taif University, Turaba, Saudi Arabia.

Abstract

Insights

Mice infected with Schistosoma mansoni develop concomitant immunity, significantly reducing worm burden, liver eggs, and granuloma size upon re-exposure. This confirms a strong host regulatory response to persistent parasitic infection.

Area of Science:

  • Immunology
  • Parasitology
  • Infectious Diseases

Background:

  • Schistosomiasis is a major parasitic disease caused by Schistosoma mansoni.
  • Concomitant immunity describes the host's ability to resist new infections while harboring existing ones.

Purpose of the Study:

  • To confirm concomitant immunity in mice infected with Schistosoma mansoni.
  • To evaluate the impact of this immunity on resistance to a secondary challenge infection.

Main Methods:

  • Mice were infected with S. mansoni cercariae and divided into experimental (challenged) and control groups.
  • Worm burdens, liver egg counts, and granuloma sizes were assessed 9 weeks post-infection.
  • Parasitological and pathological evaluations were performed on mouse livers.

Main Results:

  • Mice with persistent S. mansoni infection exhibited a significant reduction in worm burden (54.66%), liver eggs (41.45%), and granuloma size (51.76%) after challenge.
  • This demonstrates a robust regulatory immune response in mice with ongoing S. mansoni infection.
  • The findings confirm the occurrence of concomitant immunity in this model.

Conclusions:

  • Concomitant immunity effectively limits new Schistosoma mansoni infections in mice.
  • This phenomenon is crucial for understanding host-parasite dynamics in schistosomiasis.
  • Further research may utilize these findings for schistosomiasis control strategies.

Related Concept Videos